[
  {
    "ts": null,
    "headline": "GILD Obtains Positive CHMP Opinion for Liver Disease Drug",
    "summary": "The CHMP recommends the approval of Gilead's seladelpar in combination with ursodeoxycholic acid for the treatment of primary biliary cholangitis in adults.",
    "url": "https://finnhub.io/api/news?id=71c8c8c26d9a4035abf80b203835d8944dc173c5536254a6c385084608a80592",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734374400,
      "headline": "GILD Obtains Positive CHMP Opinion for Liver Disease Drug",
      "id": 132019108,
      "image": "https://media.zenfs.com/en/zacks.com/79b7ecb3a59852f0816e6eb69c31b2fe",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "The CHMP recommends the approval of Gilead's seladelpar in combination with ursodeoxycholic acid for the treatment of primary biliary cholangitis in adults.",
      "url": "https://finnhub.io/api/news?id=71c8c8c26d9a4035abf80b203835d8944dc173c5536254a6c385084608a80592"
    }
  },
  {
    "ts": null,
    "headline": "Gilead (GILD) Upgraded to Buy: Here's Why",
    "summary": "Gilead (GILD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.",
    "url": "https://finnhub.io/api/news?id=6a03e1a4aee9c2da6dc998ba3a7298342da80c562cc7c3ab265305147a30a3c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734368413,
      "headline": "Gilead (GILD) Upgraded to Buy: Here's Why",
      "id": 132019109,
      "image": "https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead (GILD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.",
      "url": "https://finnhub.io/api/news?id=6a03e1a4aee9c2da6dc998ba3a7298342da80c562cc7c3ab265305147a30a3c0"
    }
  },
  {
    "ts": null,
    "headline": "American Century Ultra Fund Q3 2024 Commentary",
    "summary": "The broad U.S. stock market posted solid gains that saw a reversal of trends from the first half of the year. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=30d50aff6e121c21c73f070a2cf619d16f40363f6bcf0607404d1f906adf3825",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734350100,
      "headline": "American Century Ultra Fund Q3 2024 Commentary",
      "id": 132012715,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1160928890/image_1160928890.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "The broad U.S. stock market posted solid gains that saw a reversal of trends from the first half of the year. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=30d50aff6e121c21c73f070a2cf619d16f40363f6bcf0607404d1f906adf3825"
    }
  },
  {
    "ts": null,
    "headline": "Gilead's Seladelpar Receives Positive CHMP Opinion for Primary Biliary Cholangitis",
    "summary": "FOSTER CITY - Gilead Sciences, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending seladelpar for...",
    "url": "https://finnhub.io/api/news?id=d7c760c958641f38c625268f2c585098c85cbd3c0c3cceb651df37e4b7355191",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734346992,
      "headline": "Gilead's Seladelpar Receives Positive CHMP Opinion for Primary Biliary Cholangitis",
      "id": 132012078,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "FOSTER CITY - Gilead Sciences, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending seladelpar for...",
      "url": "https://finnhub.io/api/news?id=d7c760c958641f38c625268f2c585098c85cbd3c0c3cceb651df37e4b7355191"
    }
  }
]